Neuroprotective Activity of Some Marine Fungal Metabolites in the 6-Hydroxydopamin- and Paraquat-Induced Parkinson's Disease Models
A new melatonin analogue 6-hydroxy-N-acetyl-β-oxotryptamine (1) was isolated from the marine-derived fungus Penicillium sp. KMM 4672. It is the second case of melatonin-related compounds isolation from microfilamentous fungi. The neuroprotective activities of this metabolite, as well as 3-methylorsellinic acid (2) and 8-methoxy-3,5-dimethylisochroman-6-ol (3) from Penicillium sp. KMM 4672, candidusin A (4) and 4″-dehydroxycandidusin A (5) from Aspergillus sp. KMM 4676, and diketopiperazine mactanamide (6) from Aspergillus flocculosus, were investigated in the 6-hydroxydopamine (6-OHDA)- and paraquat (PQ)-induced Parkinson’s disease (PD) cell models. All of them protected Neuro2a cells against the damaging influence of 6-OHDA to varying degrees. This effect may be realized via a reactive oxygen species (ROS) scavenging pathway. The new melatonin analogue more effectively protected Neuro2A cells against the 6-OHDA-induced neuronal death, in comparison with melatonin, as well as against the PQ-induced neurotoxicity. Dehydroxylation at C-3″ and C-4″ significantly increased free radical scavenging and neuroprotective activity of candidusin-related p-terphenyl polyketides in both the 6-OHDA- and PQ-induced PD models.
Citations by journals
1
2
3
4
5
|
|
Marine Drugs
|
Marine Drugs
5 publications, 17.24%
|
International Journal of Molecular Sciences
|
International Journal of Molecular Sciences
4 publications, 13.79%
|
Molecules
|
Molecules
3 publications, 10.34%
|
RSC Advances
|
RSC Advances
2 publications, 6.9%
|
Biomedicines
|
Biomedicines
1 publication, 3.45%
|
Journal of Fungi
|
Journal of Fungi
1 publication, 3.45%
|
Phytochemistry
|
Phytochemistry
1 publication, 3.45%
|
PLoS ONE
|
PLoS ONE
1 publication, 3.45%
|
Marine Life Science & Technology
|
Marine Life Science & Technology
1 publication, 3.45%
|
Pharmacological Research
|
Pharmacological Research
1 publication, 3.45%
|
Chinese Journal of Chemistry
|
Chinese Journal of Chemistry
1 publication, 3.45%
|
Brazilian Journal of Microbiology
|
Brazilian Journal of Microbiology
1 publication, 3.45%
|
Natural Product Reports
|
Natural Product Reports
1 publication, 3.45%
|
CNS and Neurological Disorders - Drug Targets
|
CNS and Neurological Disorders - Drug Targets
1 publication, 3.45%
|
Oxygen
|
Oxygen
1 publication, 3.45%
|
Metabolites
|
Metabolites
1 publication, 3.45%
|
Neurodegenerative disease management
|
Neurodegenerative disease management
1 publication, 3.45%
|
1
2
3
4
5
|
Citations by publishers
2
4
6
8
10
12
14
16
|
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
16 publications, 55.17%
|
Royal Society of Chemistry (RSC)
|
Royal Society of Chemistry (RSC)
3 publications, 10.34%
|
Elsevier
|
Elsevier
2 publications, 6.9%
|
Springer Nature
|
Springer Nature
2 publications, 6.9%
|
Public Library of Science (PLoS)
|
Public Library of Science (PLoS)
1 publication, 3.45%
|
Wiley
|
Wiley
1 publication, 3.45%
|
Bentham Science
|
Bentham Science
1 publication, 3.45%
|
Future Medicine
|
Future Medicine
1 publication, 3.45%
|
2
4
6
8
10
12
14
16
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.